NIH funded a project to manipulate coronaviruses in Wuhan so they would be able to infect humans
NIH funded a project to manipulate coronaviruses in Wuhan so they would be able to infect humans
web.archive.org /save/https%3A%2F%2Fwww.nih.gov%2Fsites%2Fdefault%2Ffiles%2Finstitutes%2Ffoia%2F2R01AI110964-year-6-tranche-05.pdf
According to the document:
- The project involved, among other tasks, performing gain-of-function on bat coronavirus SARSr-CoV WIV1, with the aim of studying its potential ability to infect humans.
- The researchers believed regulations on gain-of-function research did not apply in this case, since the original virus did not affect humans, despite the desired product virus being able to do so.
- Their risk assessment does not include the possibility of the newly created virus accidentally infecting workers or human research subjects.
- The resulting viruses were to be tested on both human tissues and modified mice with human ACE2 enzyme.
- Human subjects from "high-risk areas" were involved on-site for non-experimental purposes.
- These experiments were performed within facilities of the Wuhan Institute of Virology.
- The phase of the project wherein these experiments were first mentioned started on June 2019.
Additionally, this adds:
- The entire project started in June 2014 and initially involved collecting virus samples from different sources, including the wildlife market in Wuhan.
0 comments